Inventor
JI NAN
US57 patents
⚠️ This page may combine multiple inventors who share the name “JI NAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYMERA THERAPEUTICS INC
28 patentsUS10874743B2Dec 29, 2020
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC38 citations98
US11352350B2Jun 7, 2022
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC20 citations94
US11292792B2Apr 5, 2022
Tricyclic CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC19 citations94
US11117889B1Sep 14, 2021
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC28 citations94
US12258341B2Mar 25, 2025
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC5 citations86
US12168057B2Dec 17, 2024
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC5 citations86
US11807636B2Nov 7, 2023
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC6 citations86
US11746120B2Sep 5, 2023
Stat degraders and uses thereof
KYMERA THERAPEUTICS INC12 citations86
US11723980B2Aug 15, 2023
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC9 citations86
US11512080B2Nov 29, 2022
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC15 citations86
US11485743B2Nov 1, 2022
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC6 citations86
US11485750B1Nov 1, 2022
STAT degraders and uses thereof
KYMERA THERAPEUTICS INC7 citations86
US11358948B2Jun 14, 2022
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC16 citations86
US11318205B1May 3, 2022
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC10 citations83
US12077555B2Sep 3, 2024
STAT degraders and uses thereof
KYMERA THERAPEUTICS INC3 citations75
US12006329B2Jun 11, 2024
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC4 citations75
US12150995B2Nov 26, 2024
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC4 citations74
US11932624B2Mar 19, 2024
MDM2 degraders and uses thereof
KYMERA THERAPEUTICS INC2 citations73
US11623932B2Apr 11, 2023
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC3 citations73
US12516068B2Jan 6, 2026
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC1 citations64
US12454520B2Oct 28, 2025
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC1 citations64
US12540127B2Feb 3, 2026
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC0 citations62
US12528785B2Jan 20, 2026
MDM2 degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations62
US11932635B2Mar 19, 2024
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC1 citations62
US11897882B2Feb 13, 2024
Tricyclic crbn ligands and uses thereof
KYMERA THERAPEUTICS INC1 citations62
US12558427B2Feb 24, 2026
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations52
US12545659B2Feb 10, 2026
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations51
US12521438B2Jan 13, 2026
SMARCA degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations50
ARTMAN III GERALD DAVID
6 patentsUS8501756B2Aug 6, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID65 citations96
US8242125B2Aug 14, 2012
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID3 citations61
US8541432B2Sep 24, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
US8492393B2Jul 23, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
US8486954B2Jul 16, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
US8431584B2Apr 30, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
ADAMS CHRISTOPHER MICHAEL
4 patentsUS9056874B2Jun 16, 2015
Complement pathway modulators and uses thereof
ADAMS CHRISTOPHER MICHAEL95 citations96
US9475806B2Oct 25, 2016
Complement factor B inhibitors and uses there of
ADAMS CHRISTOPHER MICHAEL6 citations71
US8846656B2Sep 30, 2014
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
ADAMS CHRISTOPHER MICHAEL2 citations59
US9505755B2Nov 29, 2016
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators
ADAMS CHRISTOPHER MICHAEL0 citations48
MITOBRIDGE INC
3 patentsUS10611790B2Apr 7, 2020
Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
MITOBRIDGE INC11 citations85
US11034670B2Jun 15, 2021
Poly-ADP ribose polymerase (PARP) inhibitors
MITOBRIDGE INC2 citations72
US11993585B2May 28, 2024
Poly-ADP ribose polymerase (PARP) inhibitors
MITOBRIDGE INC0 citations62
HONG KONG CENTRE FOR CEREBRO CARDIOVASCULAR HEALTH ENGINEERING LTD
3 patentsUS11963782B2Apr 23, 2024
Method and apparatus of analyzing the ECG frequency parameters for the diagnosis of STEMI diseases
HONG KONG CENTRE FOR CEREBRO CARDIOVASCULAR HEALTH ENGINEERING LTD0 citations59
US12593991B2Apr 7, 2026
Method and a device for calibrating a blood pressure estimation model for determining tonoarteriogram signals
HONG KONG CENTRE FOR CEREBRO CARDIOVASCULAR HEALTH ENGINEERING LTD0 citations48
US12364402B2Jul 22, 2025
Multi-modal sensor module and a multi-modal physiological signal monitoring system
HONG KONG CENTRE FOR CEREBRO CARDIOVASCULAR HEALTH ENGINEERING LTD0 citations48
ORSOBIO INC
2 patentsADAMS CHRISTOPHER
1 patentNOVARTIS AG
1 patentADAMS CHRISTOPHER M
1 patentHONG KONG CENTRE FOR CEREBRO CARDIOVASCULER HEALTH ENGINEERING LTD
1 patentShowing the top 50 of 57 patents by PatentIndex Score.